GlassScriptPhysician profile
Hunter J Reed
NPI 1356926992
$3,940.13
in general payments reported to CMS, 2019-2025
40 companies · $636 in 2025
The $636 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $614 · 2022: $1,335 · 2023: $758 · 2024: $597 · 2025: $636.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,896 · Education: $94.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,896.09 |
| Education | $94.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $971.46 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $485.87 | 2021-2025 | |
| Glaxosmithkline, LLC. | $276.98 | 2022-2025 | Trelegy Ellipta |
| Lilly USA, LLC | $220.41 | 2021-2025 | Mounjaro, Zepbound |
| Takeda Pharmaceuticals U.S.A., INC. | $156.81 | 2022-2025 | Trintellix |
| Amgen INC. | $149.19 | 2021-2024 | Otezla, Repatha |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $134.91 | 2022-2025 | Xifaxan, Trulance |
| Astellas Pharma US INC | $132.52 | 2021-2023 | |
| Axsome Therapeutics, INC. | $120.90 | 2023-2025 | Auvelity |
| Janssen Pharmaceuticals, INC | $97.24 | 2021-2022 | |
| Nestle Healthcare Nutrition INC. | $86.17 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $84.77 | 2023-2025 | Farxiga, Breztri |
| Jazz Pharmaceuticals INC. | $84.51 | 2022 | |
| Pfizer INC. | $78.97 | 2022-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $74.04 | 2022-2023 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hunter Reed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.